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ABSTRACT 
ANALYSIS SERUM P1NP LEVELS ON BONE REGENERATION  
IN EPILEPSY PATIENS WITH LONG-TERM  
VALPROATE OR PHENYTOIN THERAPY 
(Study at Ambulatory Care of Neurology Department, Haji General Hospital 
Surabaya) 
 
BACKGROUND – According to WHO 2018, epilepsy affects ~50 million people 
worldwide. Mortality rates of epilepsy in the developing countries are reported to be higher 
than under developed countries. Patients with epilepsy have a risk of fractures about 2-6 
times greater than general population. Valproate and phenytoin reported to be associated 
with decreased bone mineral density (BMD), changes in bone turnover and increased risk 
of fractures. 
OBJECTIVE – The aim of this prospective study was to analyze serum P1NP levels as 
marker of bone formation in epilepsy patients who received long-term valproate or 
phenytoin therapy. 
METHOD – The serum P1NP levels were measured on routine patient visit to ambulatory 
care of neurology department. Sample was collected by consecutive sampling in cross 
sectional study from August – September 2018. Protocol of this study had been reviewed 
by Ethical Committee Haji General Hospital Surabaya. P1NP were measured with ELISA 
and statistical analysis was analyzed by Independent T Test and Pearson correlation. 
RESULT – A total of 22 patients participated in this study. The serum P1NP levels were 
obtained in the valproate group (mean 182.63 ± 18.24ng/ml) lower than phenytoin group 
(mean 451 ± 105,1ng/ml) in long term use with normal reference in healthy subject (20-
480ng/ml). No correlation was found between serum P1NP levels with age, gender, height, 
body mass index (BMI), and duration of AED.  
CONCLUSION – Patients with a history of prolonged use of valproate or phenytoin 
suggested for BMD testing and recommended for supplementation of calcium and vitamin 
D due to risk of fractures. 
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